New Scientist article The stocks to watch in the pharmaceutical industry are up sharply as a result of the US government’s decision to cut its budget.
The pharmaceuticals sector is now worth about $30 trillion.
The world’s biggest drugmaker Pfizer (PFE) has more than tripled in value, from $4.3bn in the first quarter of 2016 to $6.4bn.
The latest data from the US Federal Reserve shows that the economy expanded by an annualised rate of 0.3% in the three months to the end of September.
There were 2.8 million fewer jobs than at the start of the year, according to the Bureau of Labor Statistics, and the unemployment rate is at its lowest level in 20 years.
And the government has announced a raft of new measures to tackle the crisis, including raising the minimum wage from $7.25 to $10 an hour and giving states and local governments more powers to enforce drug use laws.
So what are the stocks to look out for?
The biggest stock is ABVIE, which is one of the biggest drugs companies in the world.
ABV, which was founded in 1988, is a biopharmaceutical company which develops drugs for treating cancer and is currently a part of the Pfizer group.
It is valued at about $40bn.ABV is currently one of only four companies in existence with an initial public offering.
Another is Valeant Pharmaceuticals, which in the past decade has grown from a start-up to one of America’s largest drugmakers.
Its shares have risen more than 400% since 2008, when it was founded by Bill Ackman.
Avalon, a UK company, has also grown rapidly in recent years.
It’s valued at more than $70bn.
The company recently completed a $30bn acquisition of AstraZeneca, a US drugmaker.
All of these companies have had strong growth in the last decade.
Some of these stocks have been relatively small.
Valeant, for example, grew by just over 5% in 2016.
But the market has been awash in growth stocks in recent times, particularly as companies like Pfizer and Astra have grown enormously.
Investors are now watching to see how these stocks will perform in the future.
What are some other stocks that might be a good buy?
Pfizer is the biggest pharmaceutical company in the US, and a good place to look for it is because its shares have more than doubled in value.
Pfizer has more of a presence in Europe and Africa than it does in the United States, and has expanded internationally.
The drugmaker also makes some of the world’s most powerful drugs.
Valeant has become a valuable investment because its stock price is up more than 40% since its initial public offer in 2007.
However, its shares are also worth about three times what it was in 2008, making it a very volatile stock.
It’s also worth watching ABV for its high growth rate.
It grew by almost 6% in 2015, so it is a good option to buy at a low price.